StockMarketWire.com - finnCap today initiates coverage of Shield Therapeutics Plc [LON:STX] with a corporate investment rating and price target of 200p.

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk